GelSana Therapeutics, Inc. — Form D/A
GelSana Therapeutics, Inc. of AURORA, CO, a company, filed a Form D amendment with the SEC on 2024-08-14. The offering totals $3.2M, of which $2.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-08-14
- Form: D/A
- Accession: 0002002665-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.2M
- Amount sold: $2.8M
- Remaining: $370K
- Investors: 17
- Date of first sale: 2023-11-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-498739
Issuer
- Name: GelSana Therapeutics, Inc.
- CIK: 0002002665
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 12635 E MONTVIEW BLVD STE 216, AURORA, CO, 80045
- Phone: (216) 502-0901
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Mike Freeman | Director | Aurora, CO |
| Melissa Krebs | Director | Aurora, CO |
| Diana Verrilli | Director | Aurora, CO |
| Jon Fernandez | Executive Officer | Aurora, CO |
| Melissa Krebs | Executive Officer | Aurora, CO |
| Diana Verrilli | Related Person | Aurora, CO |
| Melissa Krebs | Related Person | Aurora, CO |
| Mike Freeman | Related Person | Aurora, CO |
| Jim Kasic | Director | Aurora, CO |
Other filings by this issuer (2)
More